BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25834405)

  • 1. Complete genome-wide screening and subtractive genomic approach revealed new virulence factors, potential drug targets against bio-war pathogen Brucella melitensis 16M.
    Pradeepkiran JA; Sainath SB; Kumar KK; Bhaskar M
    Drug Des Devel Ther; 2015; 9():1691-706. PubMed ID: 25834405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M.
    Pradeepkiran JA; Kumar KK; Kumar YN; Bhaskar M
    Drug Des Devel Ther; 2015; 9():1897-912. PubMed ID: 25848225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the virulence of a Brucella melitensis hemagglutinin gene in the caprine model.
    Perry QL; Hagius SD; Walker JV; Elzer PH
    Vaccine; 2010 Oct; 28 Suppl 5():F6-11. PubMed ID: 20362205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genome-wide Core Proteome Analysis of Brucella melitensis Strains for Potential Drug Target Prediction.
    Rahman N; Shah M; Muhammad I; Khan H; Imran M
    Mini Rev Med Chem; 2021; 21(18):2778-2787. PubMed ID: 32634082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Phosphoribosyl-AMP cyclohydrolase, as drug target and its inhibitors in Brucella melitensis bv. 1 16M using metabolic pathway analysis.
    Gupta M; Prasad Y; Sharma SK; Jain CK
    J Biomol Struct Dyn; 2017 Feb; 35(2):287-299. PubMed ID: 26725317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular screening for rifampicin and fluoroquinolone resistance in a clinical population of Brucella melitensis.
    Valdezate S; Navarro A; Medina-Pascual MJ; Carrasco G; Saéz-Nieto JA
    J Antimicrob Chemother; 2010 Jan; 65(1):51-3. PubMed ID: 19861338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A multicopper oxidase contributes to the copper tolerance of Brucella melitensis 16M.
    Wu T; Wang S; Wang Z; Peng X; Lu Y; Wu Q
    FEMS Microbiol Lett; 2015 Jun; 362(12):fnv078. PubMed ID: 25956175
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The identification of two protective DNA vaccines from a panel of five plasmid constructs encoding Brucella melitensis 16M genes.
    Commander NJ; Spencer SA; Wren BW; MacMillan AP
    Vaccine; 2007 Jan; 25(1):43-54. PubMed ID: 17049676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Draft genome sequence of field isolate Brucella melitensis strain 2007BM/1 from India.
    Singh DK; Kumar B; Shrinet G; Singh RP; Das A; Mantur BG; Abhishek ; Pandey A; Mondal P; Sajjanar BK; Doimari S; Singh V; Kumari R; Tiwari AK; Gandham RK
    J Glob Antimicrob Resist; 2018 Jun; 13():152-153. PubMed ID: 29684575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
    Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
    Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Brucella melitensis 16M genes required for bacterial survival in the caprine host.
    Zygmunt MS; Hagius SD; Walker JV; Elzer PH
    Microbes Infect; 2006; 8(14-15):2849-54. PubMed ID: 17090391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of OtpR regulated sRNAs in Brucella melitensis expressed under acidic stress and their roles in pathogenesis and metabolism.
    Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
    Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():40-47. PubMed ID: 28131377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic analysis of the original Elberg Brucella melitensis Rev.1 vaccine strain reveals insights into virulence attenuation.
    Salmon-Divon M; Yeheskel A; Kornspan D
    Virulence; 2018; 9(1):1436-1448. PubMed ID: 30139304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Vaccine Candidates against Brucella melitensis Identified through Reverse Vaccinology Approach.
    Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
    OMICS; 2015 Nov; 19(11):722-9. PubMed ID: 26479901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of RegM on stress responses in Brucella melitensis.
    Dong H; Liu W; Peng X; Wu Q
    Curr Microbiol; 2015 May; 70(5):730-4. PubMed ID: 25648428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling, molecular docking, probing catalytic binding mode of acetyl-CoA malate synthase G in
    Adi PJ; Yellapu NK; Matcha B
    Biochem Biophys Rep; 2016 Dec; 8():192-199. PubMed ID: 28955956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OtpR regulated the growth, cell morphology of B. melitensis and tolerance to β-lactam agents.
    Liu W; Dong H; Liu W; Gao X; Zhang C; Wu Q
    Vet Microbiol; 2012 Sep; 159(1-2):90-8. PubMed ID: 22503392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ton system, an ABC transporter, and a universally conserved GTPase are involved in iron utilization by Brucella melitensis 16M.
    Danese I; Haine V; Delrue RM; Tibor A; Lestrate P; Stevaux O; Mertens P; Paquet JY; Godfroid J; De Bolle X; Letesson JJ
    Infect Immun; 2004 Oct; 72(10):5783-90. PubMed ID: 15385478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and implementation of a database for Brucella melitensis genome annotation.
    De Hertogh B; Lahlimi L; Lambert C; Letesson JJ; Depiereux E
    Vet Microbiol; 2008 Mar; 127(3-4):369-78. PubMed ID: 18160234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brucella melitensis 16MΔhfq attenuation confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Guo F; Chen C; Li Z; Zhang H; Wang Y; Zhang K; Du G; Li Y; Wang J; Jian T; Wang Z
    Microbiol Immunol; 2013 Jul; 57(7):502-10. PubMed ID: 23647412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.